These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24354448)

  • 21. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
    Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clozapine--the neglected potential].
    Munitz H
    Harefuah; 2012 May; 151(5):298-300, 318, 317. PubMed ID: 22844735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S; Rosenius S; Spigset O
    Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed initiation of clozapine may be related to poor response in treatment-resistant schizophrenia.
    Üçok A; Çikrikçili U; Karabulut S; Salaj A; Öztürk M; Tabak Ö; Durak R
    Int Clin Psychopharmacol; 2015 Sep; 30(5):290-5. PubMed ID: 26163875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is clozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia?
    Karunakaran K; Tungaraza TE; Harborne GC
    J Psychopharmacol; 2007 Jun; 21(4):453-6. PubMed ID: 17050662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study.
    Nielsen J; Nielsen RE; Correll CU
    J Clin Psychopharmacol; 2012 Oct; 32(5):678-83. PubMed ID: 22926603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of clozapine versus other antipsychotics on clinical outcome and dopamine release in the brain.
    Advokat C
    Essent Psychopharmacol; 2005; 6(2):73-90. PubMed ID: 15765792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of ziprasidone and clozapine in treatment-resistant schizophrenia.
    Zink M; Mase E; Dressing H
    Hum Psychopharmacol; 2004 Jun; 19(4):271-3. PubMed ID: 15181656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clozapine use and abrupt smoking cessation; a potentially life-threatening combination].
    Ruissen A; van Schaik AM; Beijnen JH
    Tijdschr Psychiatr; 2009; 51(9):699-703. PubMed ID: 19760570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of treatment-resistant patients with schizophrenia.
    Marder SR
    J Clin Psychiatry; 1996; 57 Suppl 11():26-30. PubMed ID: 8941168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study.
    Ronaldson KJ; Fitzgerald PB; Taylor AJ; Topliss DJ; Wolfe R; McNeil JJ
    Schizophr Res; 2012 Nov; 141(2-3):173-8. PubMed ID: 23010488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotic reexposure and recurrent pneumonia in schizophrenia: a nested case-control study.
    Hung GC; Liu HC; Yang SY; Pan CH; Liao YT; Chen CC; Kuo CJ
    J Clin Psychiatry; 2016 Jan; 77(1):60-6. PubMed ID: 26613551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics.
    Scheepers FE; de Wied CC; Hulshoff Pol HE; van de Flier W; van der Linden JA; Kahn RS
    Neuropsychopharmacology; 2001 Jan; 24(1):47-54. PubMed ID: 11106875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between initial pattern of clozapine titration, concentration-to-dose ratio, and incidence of fever in patients with schizophrenia spectrum disorders in a Korean tertiary hospital.
    Kang N; Kim SH; Kim J; Kim S; Jang J; Yoon H; Lee J; Kim M; Kim YS; Kwon JS
    Schizophr Res; 2024 Jun; 268():131-137. PubMed ID: 37633775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient response and resource management: another view of clozapine treatment of schizophrenia.
    Carpenter WT; Conley RR; Buchanan RW; Breier A; Tamminga CA
    Am J Psychiatry; 1995 Jun; 152(6):827-32. PubMed ID: 7755110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine use in geriatric patients- Challenges.
    Mukku SSR; Sivakumar PT; Varghese M
    Asian J Psychiatr; 2018 Mar; 33():63-67. PubMed ID: 29529421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Clozapine with Seizures: A Brief Report Involving 222 Patients Prescribed Clozapine.
    Grover S; Hazari N; Chakrabarti S; Avasthi A
    East Asian Arch Psychiatry; 2015 Jun; 25(2):73-8. PubMed ID: 26118746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined use of clozapine and ECT: a review.
    Grover S; Hazari N; Kate N
    Acta Neuropsychiatr; 2015 Jun; 27(3):131-42. PubMed ID: 25697225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Clozapine Delay on Clinical Outcomes in Schizophrenia.
    Law C; See YM; Yee JY; Ng BT; Tang C; Lee J
    J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37616477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.